Related to FDA Clears Beckman Coulter’s phi Blood Test for Prostate Cancer

• FDA Clears Qiagen’s Rotor-Gene MDx RT-PCR IVD Platform and Influenza Assay
  
• FDA Clears Leica’s Her2 Immunohistochemical Assay on Bond-Max Instrument
  
• FDA Requests More Risk-Benefit Data for Amgen’s Xgeva sBLA in Prostate Cancer
  
• FDA Clears Immunetics' Rapid Test for Bacterial Contamination of Platelet Units
  
• FDA Approves Nanosphere’s Blood Infection Assay
  
• FDA Approves Roche's HIV Test
  
• FDA Sanctions Roche’s CMV Test
  
• FDA Clears BD MAX MRSA Test
  
• FDA Clears First New G-CSF Neutropenia Therapy in 10 Years
  
• FDA Okay for Respiratory Virus Test Panel
  
• FDA Okays Meridian’s Strep Throat Diagnostic
  
• CE Mark for NanoString’s PAM50 Breast Cancer Test
  
• Novel Treatment for Most Common Type of Lung Cancer
  
• FDA Approves Novartis' Flucelvax
  
• Exelixis Scores First FDA Approval for Thyroid Cancer Drug
  
• FDA Blocks Novo, Boosts Celgene
  
• Roche's Genentech Wins FDA OK for Breast Cancer Drug
  
• FDA Clears Gen-Probe’s PCA3 Urine Assay for Predicting Need for Repeat Prostate Biopsies
  
• FDA Approves Qiagen’s KRAS Companion Diagnostic And New Use for Erbitux
  
• Bayer Prostate Cancer Drug Gains FDA Approval